|
Genes with increased expression in synovial fibroblasts from DA.F344 (Cia5d) compared with DA |
|||||||
| Gene Symbold |
Definitiona |
Accession number |
DA mean |
Cia5d mean |
Fold change |
P valueb |
Overall rankc |
|
|
|||||||
| Cancer, Cell Cycle, DNA replication, recombination and repair |
|||||||
| Gadd45b |
Growth arrest and DNA-damage-inducible 45 beta |
NM_001008321.1 |
214.12 |
412.97 |
1.9 |
0.00572 |
39 |
| Gmfg |
Glia maturation factor, gamma (Gmfg) |
NM_181091.2 |
1359.39 |
2261.87 |
1.7 |
0.00817 |
54 |
| Plekhg2_predicted |
Pleckstrin homology domain containing, family G (with RhoGef domain) member 2 (predicted) |
XM_214862.3 |
91.97 |
147.62 |
1.6 |
0.00784 |
52 |
| Lox |
Lysyl oxidase |
XM_579391.1 |
15755.11 |
24559.79 |
1.6 |
0.00198 |
12 |
| Brwd3_predicted |
Similar to bromo domain-containing protein disrupted in leukemia (LOC317213) |
XM_228518.3 |
43.85 |
52.99 |
1.2 |
0.00596 |
43 |
| Aph1a |
Similar to anterior pharynx defective 1 homolog A (C. elegans) |
XM_345251.2 |
2820.66 |
3246.28 |
1.2 |
0.00046 |
4 |
| Pex19_predictede |
Peroxisome biogenesis factor 19 (predicted) |
XM_225711.3 |
119.41 |
135.98 |
1.1 |
0.00561 |
38 |
| Cell Signaling |
|||||||
| Fkbp7_predicted |
FK506 binding protein 7 (predicted) |
XM_215758.3 |
784.02 |
1450.53 |
1.9 |
0.00578 |
40 |
| Ncor1 |
Nuclear receptor co-repressor 1 |
XM_577103.1 |
420.35 |
679.65 |
1.6 |
0.00454 |
32 |
| Tap1 |
Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
NM_032055.1 |
190.32 |
288.49 |
1.5 |
0.00878 |
61 |
| Prnp |
Prion protein |
XM_579340.1 |
17242.89 |
24050.29 |
1.4 |
0.00029 |
3 |
| Fzd4 |
Frizzled homolog 4 (Drosophila) |
NM_022623.1 |
44.45 |
60.14 |
1.4 |
0.00406 |
26 |
| Gene expression |
|||||||
| H1f0 |
H1 histone family, member 0 |
NM_012578.2 |
150.12 |
229.40 |
1.5 |
0.00707 |
47 |
| Cell-Cell Interaction |
|||||||
| Fath |
Hypothetical gene supported by NM_031819; Fath fat tumor suppressor homolog (Drosophila) |
XM_579538.1 |
3803.04 |
5806.86 |
1.5 |
0.00206 |
13 |
| Extracellular Matrix |
|||||||
| Col5a1 |
Collagen, type V, alpha 1 (Col5a1) |
NM_134452.1 |
7240.26 |
9852.22 |
1.4 |
0.00807 |
53 |
| Others |
|||||||
| Gtlf3b_predicted |
Gene trap locus F3b (predicted) |
XM_343907.2 |
78.16 |
175.41 |
2.2 |
0.00003 |
1 |
| Olfml2b_predicted |
Olfactomedin-like 2B (predicted) |
XM_222868.3 |
1336.30 |
2949.43 |
2.2 |
0.00241 |
17 |
| Gsdmdc1_predicted |
Gasdermin domain containing 1 (predicted) |
XM_235434.3 |
458.74 |
831.39 |
1.8 |
0.00295 |
20 |
| Trim41_predicted |
Tripartite motif-containing 41 (predicted) |
XM_220357.3 |
422.66 |
732.37 |
1.7 |
0.00100 |
7 |
| LOC498815 |
Hypothetical gene supported by AY771707 |
XM_579873.1 |
243.56 |
366.68 |
1.5 |
0.00281 |
19 |
| LOC304860 |
Similar to N-acetylneuraminate pyruvate lyase |
XM_222736.3 |
270.64 |
401.65 |
1.5 |
0.00176 |
11 |
| Setdb2_predicted |
SET domain, bifurcated 2 (predicted) |
XM_224248.3 |
94.38 |
136.31 |
1.4 |
0.00945 |
66 |
| LOC361448 |
Similar to cDNA sequence BC013529 (predicted) |
XM_341726.2 |
2852.12 |
4043.46 |
1.4 |
0.00071 |
5 |
| LOC360899 |
Similar to SERTA domain containing 4 |
XM_341174.2 |
1771.29 |
2489.20 |
1.4 |
0.00886 |
63 |
| Ormdl2_predicted |
ORM1-like 2 (S. cerevisiae) (predicted) |
XM_213832.3 |
1996.56 |
2773.15 |
1.4 |
0.00549 |
37 |
| LOC498067 |
Similar to RIKEN cDNA 2310003P10 (LOC498067), mRNA. |
XM_573266.1 |
368.00 |
494.10 |
1.3 |
0.00860 |
58 |
| Nit1 |
Nitrilase 1 |
NM_182668.1 |
3397.58 |
4472.84 |
1.3 |
0.00296 |
21 |
| Fam18b_predicted |
Family with sequence similarity 18, member B (predicted) |
XM_219680.3 |
2915.92 |
3746.20 |
1.3 |
0.00447 |
31 |
| Ubxd2_predicted |
UBX domain containing 2 (predicted) |
XM_573443.1 |
2018.75 |
2569.23 |
1.3 |
0.00411 |
27 |
|
aEstrogen; ER, estrogen-induced, or estrogen-receptor signaling or degradation are marked in bold. bt test. cOrder (logistic regression) in the list of 66 genes differentially expressed between DA and DA.F344(Cia5d). dCancer and invasion associated genes are in italics. eIncreased expression in invading breast cancers. | |||||||
Laragione et al. Arthritis Research & Therapy 2008 10:R92 doi:10.1186/ar2476 |
|||||||